Craig Lipset served as Head of Clinical Innovation within Global Product Development at Pfizer. He led the strategy and development of new approaches for clinical research through digital tools, innovative research approaches and game-changing collaborations. Craig previously served as Venture Partner in Pfizer Venture Investments (Pfizer’s VC arm), where he focused on diversifying the company’s $50M annual budget for private investments in the areas of diagnostics and health technology. Craig was also Senior Director in Molecular Medicine, where he spearheaded initiatives driving innovation in clinical research and personalized medicine by drawing upon tools from health information technology, telemedicine, and eHealth.

Craig brings over 15 years of leadership and innovation in the field of drug development, including having served on the founding Operations Committee at TransCelerate Biopharma. He previously served as Associate Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), and on the founding management team for Perceptive Informatics (now part of PAREXEL International). Craig has been listed among the PharmaVOICE most inspiring people in the life sciences, Pharmaceutical Executive’s Emerging Leaders, CenterWatch Top Innovators, and AlleyWatch Who's Who in eHealth.

Craig serves on the Board of Directors for the People-Centered Research Foundation, Foundation for Sarcoidosis Research and MedStar Health Research Institute, and is a Mentor at health tech accelerator Blueprint Health. He also serves on the Editorial Board for Therapeutic Innovation & Regulatory Science.